Switzerland
Industry
Switzerland-based Actelion, Europe's biggest biotech company, achieved a 20% increase in revenues in 2009, to US$1.65bn from US$1.37bn in 2008, aided by the strong sales of its top-selling...
2010-02-22Industry
US based Cephalon is to acquire Swiss generic drugmaker Mepha AG and its subsidiaries from the family of the late German billionaire Adolf Merckle for US$590mn. The transaction is...
2010-02-04Industry
Swiss drugmaker Roche has posted strong results for 2009, highlighting the opportunities that pandemics such as swine flu can provide to drug companies. The company has reported...
2010-02-03Industry
Despite the economic downturn, Swiss drugmaker Novartis has posted a strong set of results for the financial year ending 2009, with record sales in the company's pharmaceutical division...
2010-01-27Industry
Multinational dug company Roche is investing approximately CHF1.90bn (US$1.82bn) in manufacturing a novel device that will allow patients to self-administer biological cancer medicines....
2010-01-21Industry
Merck Serono has become the latest multinational to establish a major research and development (R&D) facility in China. The Geneva-headquartered firm will leverage the country's...
2009-11-25Industry
With the aim of banning doctors in Switzerland dispensing medicines, the country's government has approved the amendment of the Heilmittelgesetz, a law that has regulated the distribution...
2009-11-20Industry
A study carried out by Swiss pharmaceutical industry and health insurance companies has revealed that the country's citizens pay significantly higher prices for generic medicines...
2009-11-19


